Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival

Hong Li, Yanru Wang, Hongliang Liu, Qiong Shi, Hongyu Li, Wenting Wu, Dakai Zhu, Christopher I. Amos, Shenying Fang, Jeffrey E. Lee, Yi Li, Jiali Han, Qingyi Wei

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

To investigate whether genetic variants of platelet-derived growth factor (PDGF) signaling pathway genes are associated with survival of cutaneous melanoma (CM) patients, we assessed associations of single-nucleotide polymorphisms in PDGF pathway with melanoma-specific survival in 858 CM patients of M.D. Anderson Cancer Center (MDACC). Additional data of 409 cases from Harvard University were also included for further analysis. We identified 13 SNPs in four genes (COL6A3, NCK2, COL5A1 and PRKCD) with a nominal P < 0.05 and false discovery rate (FDR) < 0.2 in MDACC dataset. Based on linkage disequilibrium, functional prediction and minor allele frequency, a representative SNP in each gene was selected. In the metaanalysis using MDACC and Harvard datasets, there were two SNPs associated with poor survival of CM patients: rs6707820 C > T in NCK2 (HR = 1.87, 95% CI = 1.35-2.59, Pmeta = 1.53E-5); and rs2306574 T > C in PRKCD (HR = 1.73, 95% CI = 1.33-2.24, Pmeta = 4.56E-6). Moreover, CM patients in MDACC with combined risk genotypes of these two loci had markedly poorer survival (HR = 2.47, 95% CI = 1.58-3.84, P < 0.001). Genetic variants of rs6707820 C > T in NCK2 and rs2306574 T > C in PRKCD of the PDGF signaling pathway may be biomarkers for melanoma survival.

Original languageEnglish (US)
Pages (from-to)74595-74606
Number of pages12
JournalOncotarget
Volume8
Issue number43
DOIs
StatePublished - Jan 1 2017

Fingerprint

Platelet-Derived Growth Factor
Melanoma
Skin
Survival
Genes
Single Nucleotide Polymorphism
Neoplasms
Biomarkers
Genotype

Keywords

  • Cox regression
  • Cutaneous melanoma
  • PDGF signaling pathway
  • Single nucleotide polymorphisms

ASJC Scopus subject areas

  • Oncology

Cite this

Li, H., Wang, Y., Liu, H., Shi, Q., Li, H., Wu, W., ... Wei, Q. (2017). Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival. Oncotarget, 8(43), 74595-74606. https://doi.org/10.18632/oncotarget.20245

Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival. / Li, Hong; Wang, Yanru; Liu, Hongliang; Shi, Qiong; Li, Hongyu; Wu, Wenting; Zhu, Dakai; Amos, Christopher I.; Fang, Shenying; Lee, Jeffrey E.; Li, Yi; Han, Jiali; Wei, Qingyi.

In: Oncotarget, Vol. 8, No. 43, 01.01.2017, p. 74595-74606.

Research output: Contribution to journalArticle

Li, H, Wang, Y, Liu, H, Shi, Q, Li, H, Wu, W, Zhu, D, Amos, CI, Fang, S, Lee, JE, Li, Y, Han, J & Wei, Q 2017, 'Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival', Oncotarget, vol. 8, no. 43, pp. 74595-74606. https://doi.org/10.18632/oncotarget.20245
Li, Hong ; Wang, Yanru ; Liu, Hongliang ; Shi, Qiong ; Li, Hongyu ; Wu, Wenting ; Zhu, Dakai ; Amos, Christopher I. ; Fang, Shenying ; Lee, Jeffrey E. ; Li, Yi ; Han, Jiali ; Wei, Qingyi. / Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival. In: Oncotarget. 2017 ; Vol. 8, No. 43. pp. 74595-74606.
@article{fe07823699fd40519de210099577a03c,
title = "Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival",
abstract = "To investigate whether genetic variants of platelet-derived growth factor (PDGF) signaling pathway genes are associated with survival of cutaneous melanoma (CM) patients, we assessed associations of single-nucleotide polymorphisms in PDGF pathway with melanoma-specific survival in 858 CM patients of M.D. Anderson Cancer Center (MDACC). Additional data of 409 cases from Harvard University were also included for further analysis. We identified 13 SNPs in four genes (COL6A3, NCK2, COL5A1 and PRKCD) with a nominal P < 0.05 and false discovery rate (FDR) < 0.2 in MDACC dataset. Based on linkage disequilibrium, functional prediction and minor allele frequency, a representative SNP in each gene was selected. In the metaanalysis using MDACC and Harvard datasets, there were two SNPs associated with poor survival of CM patients: rs6707820 C > T in NCK2 (HR = 1.87, 95{\%} CI = 1.35-2.59, Pmeta = 1.53E-5); and rs2306574 T > C in PRKCD (HR = 1.73, 95{\%} CI = 1.33-2.24, Pmeta = 4.56E-6). Moreover, CM patients in MDACC with combined risk genotypes of these two loci had markedly poorer survival (HR = 2.47, 95{\%} CI = 1.58-3.84, P < 0.001). Genetic variants of rs6707820 C > T in NCK2 and rs2306574 T > C in PRKCD of the PDGF signaling pathway may be biomarkers for melanoma survival.",
keywords = "Cox regression, Cutaneous melanoma, PDGF signaling pathway, Single nucleotide polymorphisms",
author = "Hong Li and Yanru Wang and Hongliang Liu and Qiong Shi and Hongyu Li and Wenting Wu and Dakai Zhu and Amos, {Christopher I.} and Shenying Fang and Lee, {Jeffrey E.} and Yi Li and Jiali Han and Qingyi Wei",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.20245",
language = "English (US)",
volume = "8",
pages = "74595--74606",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "43",

}

TY - JOUR

T1 - Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival

AU - Li, Hong

AU - Wang, Yanru

AU - Liu, Hongliang

AU - Shi, Qiong

AU - Li, Hongyu

AU - Wu, Wenting

AU - Zhu, Dakai

AU - Amos, Christopher I.

AU - Fang, Shenying

AU - Lee, Jeffrey E.

AU - Li, Yi

AU - Han, Jiali

AU - Wei, Qingyi

PY - 2017/1/1

Y1 - 2017/1/1

N2 - To investigate whether genetic variants of platelet-derived growth factor (PDGF) signaling pathway genes are associated with survival of cutaneous melanoma (CM) patients, we assessed associations of single-nucleotide polymorphisms in PDGF pathway with melanoma-specific survival in 858 CM patients of M.D. Anderson Cancer Center (MDACC). Additional data of 409 cases from Harvard University were also included for further analysis. We identified 13 SNPs in four genes (COL6A3, NCK2, COL5A1 and PRKCD) with a nominal P < 0.05 and false discovery rate (FDR) < 0.2 in MDACC dataset. Based on linkage disequilibrium, functional prediction and minor allele frequency, a representative SNP in each gene was selected. In the metaanalysis using MDACC and Harvard datasets, there were two SNPs associated with poor survival of CM patients: rs6707820 C > T in NCK2 (HR = 1.87, 95% CI = 1.35-2.59, Pmeta = 1.53E-5); and rs2306574 T > C in PRKCD (HR = 1.73, 95% CI = 1.33-2.24, Pmeta = 4.56E-6). Moreover, CM patients in MDACC with combined risk genotypes of these two loci had markedly poorer survival (HR = 2.47, 95% CI = 1.58-3.84, P < 0.001). Genetic variants of rs6707820 C > T in NCK2 and rs2306574 T > C in PRKCD of the PDGF signaling pathway may be biomarkers for melanoma survival.

AB - To investigate whether genetic variants of platelet-derived growth factor (PDGF) signaling pathway genes are associated with survival of cutaneous melanoma (CM) patients, we assessed associations of single-nucleotide polymorphisms in PDGF pathway with melanoma-specific survival in 858 CM patients of M.D. Anderson Cancer Center (MDACC). Additional data of 409 cases from Harvard University were also included for further analysis. We identified 13 SNPs in four genes (COL6A3, NCK2, COL5A1 and PRKCD) with a nominal P < 0.05 and false discovery rate (FDR) < 0.2 in MDACC dataset. Based on linkage disequilibrium, functional prediction and minor allele frequency, a representative SNP in each gene was selected. In the metaanalysis using MDACC and Harvard datasets, there were two SNPs associated with poor survival of CM patients: rs6707820 C > T in NCK2 (HR = 1.87, 95% CI = 1.35-2.59, Pmeta = 1.53E-5); and rs2306574 T > C in PRKCD (HR = 1.73, 95% CI = 1.33-2.24, Pmeta = 4.56E-6). Moreover, CM patients in MDACC with combined risk genotypes of these two loci had markedly poorer survival (HR = 2.47, 95% CI = 1.58-3.84, P < 0.001). Genetic variants of rs6707820 C > T in NCK2 and rs2306574 T > C in PRKCD of the PDGF signaling pathway may be biomarkers for melanoma survival.

KW - Cox regression

KW - Cutaneous melanoma

KW - PDGF signaling pathway

KW - Single nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=85030101102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030101102&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.20245

DO - 10.18632/oncotarget.20245

M3 - Article

VL - 8

SP - 74595

EP - 74606

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 43

ER -